DRUG · Mapped RxNorm record
Insulin LISPRO
Normalized identity: insulin lisproView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
NCT01792323
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAbsorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Insulin LISPRODRUG · verified · RxNorm: insulin lispro
Sponsors & collaborators
Medical University of Grazlead sponsor
European Commissioncollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01792323 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.